ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

WaferGen to Present at 13th Annual BIO CEO and Investor Conference

Print | 
Email |  Comment   Share  

(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)

WaferGen Biosystems, Inc.
Bayside Technology Center
Fremont, CA, 94538
USA



Press release date: February 2, 2011

FREMONT, Calif., Feb. 2, 2011 - WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that it will present an overview of the company at the 13th annual BIO CEO and Investor Conference in New York City at the Waldorf Astoria Hotel, Tuesday, February 15, 2011 at 11:30 a.m. Eastern time. The presentation will be webcast live and archived for 90 days and may be accessed at www.wafergen.com.

The BIO CEO and Investor Conference is an international biotechnology investor conference featuring established and emerging public companies. For additional information, see http://www.bio.org/bioceo/.

WaferGen Biosystems, Inc. is a leader in the development, manufacture and sale of state-of-the-art systems for genomic analysis for the life science and pharmaceutical industries. The company currently offers the breakthrough SmartChip Real-Time PCR system, the next-generation Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform. The company believes that the SmartChip system is ideal for researchers seeking to confirm discoveries made with the growing use of next-generation sequencing. In addition, the high throughput capabilities of the SmartChip system enable scientists to extend their research across large panels of genes, and hundreds of samples, at a very reasonable cost.

In addition, the company offers an innovative fee-based service for gene-expression profiling using the SmartChip system. For additional information, please see http://www.wafergen.com.

SOURCE WaferGen Biosystems, Inc.

WaferGen 510-651-4450 Don Huffman, CFO don.huffman@wafergen.com

Joyce Strand joyce.strand@wafergen.com

Web Site: http://www.bio.org/bioceo/
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



-- IMT - News | IMTREG2 |  18716 --
Start Your Free
Subscription to
Industry Market Trends.
 More New Product News from this company:
Open Platform Gene Sampling Chips suit SmartChip System.
Real-Time PCR System offers pathway-based biomarker discovery.
Multi-Sample Dispenser accelerates biomarker validation.
More ....
 Other News from this company:
WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System
WaferGen Announces USC Purchases SmartChip System to Expedite Development of Cancer Therapy through More Effective Biomarker Profiling
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-Mail Story
Save Story


Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2013 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy



Error close

Please enter a valid email address